Sanveer Singh Dhillon. (2012). Phase-II clinical trial assessing safety and efficacy of ex-vivo expanded allogenic mesenchymal stem cells for chronic critical limb ischemia.
Chicago Style (17th ed.) CitationSanveer Singh Dhillon. Phase-II Clinical Trial Assessing Safety and Efficacy of Ex-vivo Expanded Allogenic Mesenchymal Stem Cells for Chronic Critical Limb Ischemia. 2012.
MLA (8th ed.) CitationSanveer Singh Dhillon. Phase-II Clinical Trial Assessing Safety and Efficacy of Ex-vivo Expanded Allogenic Mesenchymal Stem Cells for Chronic Critical Limb Ischemia. 2012.
Warning: These citations may not always be 100% accurate.